TRCT
CING icon

Tower Research Capital (TRC)’s Cingulate CING Stock Holding History

Tower Research Capital (TRC)’s Portfolio CING Stock Details CING Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.3K Sell
531
-340
-39% -$2.17K ﹤0.01% 4336
2025
Q4 		$3.78K Buy
+871
New +$3.36K ﹤0.01% 4314
2025
Q3 		– Sell
-1,701
Closed -$6.92K – 5259
2025
Q2 		$6.92K Buy
1,701
+1,268
+293% +$5.18K ﹤0.01% 4079
2025
Q1 		$1.86K Sell
433
-331
-43% -$1.44K ﹤0.01% 4633
2024
Q4 		$3.77K Sell
764
-808
-51% -$3.54K ﹤0.01% 4596
2024
Q3 		$7.92K Buy
1,572
+1,069
+213% +$6.05K ﹤0.01% 4004
2024
Q2 		$1.93K Sell
503
-171
-25% -$1.66K ﹤0.01% 5076
2024
Q1 		$8.89K Buy
674
+606
+891% +$19.4K ﹤0.01% 3938
2023
Q4 		$6.2K Buy
68
+34
+100% +$2.94K ﹤0.01% 4770
2023
Q3 		$5.84K Hold
34
– – ﹤0.01% 4680
2023
Q2 		$7.68K Sell
34
-11
-24% -$2.63K ﹤0.01% 4536
2023
Q1 		$11K Buy
45
+7
+18% +$1.86K ﹤0.01% 4192
2022
Q4 		$9K Sell
38
-8
-17% -$1.97K ﹤0.01% 4174
2022
Q3 		$12K Buy
46
+31
+207% +$10.7K ﹤0.01% 4325
2022
Q2 		$5K Buy
15
+7
+88% +$2.42K ﹤0.01% 5038
2022
Q1 		$4K Buy
+8
New +$3.52K ﹤0.01% 5185

Other funds holding CING

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Tower Research Capital (TRC)'s CING Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Cingulate (CING) stake by 39% in Q1 2026, selling an estimated $2.17K and leaving 531 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4336.

Tower Research Capital (TRC) first reported a position in CING in Q1 2022 and has held it in 16 quarters since. The position peaked at $12K in Q3 2022. 27 funds tracked by Wall St. Rank hold CING as of Q1 2026.

  • Tower Research Capital (TRC) held 531 shares of Cingulate worth $3.3K as of Q1 2026.
  • Tower Research Capital (TRC) sold 340 Cingulate shares in Q1 2026, an estimated $2.17K.
  • Cingulate made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4336 holding.
  • Tower Research Capital (TRC) first reported a position in Cingulate in Q1 2022 and has held it in 16 quarters since.
  • Tower Research Capital (TRC)'s Cingulate position peaked at $12K in Q3 2022.
  • 27 funds tracked by Wall St. Rank held Cingulate as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.